Search biotechnologie laval biotechnologie montreal
Rechercher scientifique biotechnologique
Home |  FR
sciences et vie laval
environnement scientifique canada
industrie pharmaceutique laval montreal
compagnies biotechnologiques canada
 
industrie biotechnologie
parcs scientifiques
innovation laval
implantation entreprise
implantation entreprise
implantation entreprise
implantation entreprise
implantation entreprise
Partner :
inrs
News
April 18 2017 - ILKOS: A BREAKTHROUGH IN BIOTECHNOLOGIES
April 3 2017 - Seminar special Quebec "Comment se développer en Amérique du Nord à partir du Canada" - April 3, 2017
December 6 2016 - Third edition of the Holiday Cocktail of the Biotech City & BIOQuébec
November 22 2016 - GREATER MONTRÉAL AND THE REGION OF LYON ARE JOINING FORCES TO GIVE A BOOST TO INTERNATIONAL LIFE SCIENCES AND HEALTH TECHNOLOGIES (LSHT) COMPANIES
September 30 2016 - The CISSS of the North Shore concentrate their labs in Laval
September 26 2016 - $21 Million Investment in Laval Biotech Start-up
June 13 2016 - Valeant Canada announces an investment of $10 million in Laval facility to increase and secure its export capacity
January 19 2016 - Valeant Canada facility in Laval to become North American production site for Jublia®
November 24 2015 - The Biotech City and BIOQuébec Cocktail
November 20 2015 - Recovery of the Laval Biopharmaceutical Industry
November 19 2015 - Dynacare doubles its workforce in Laval
November 18 2015 - New partnership between CTS Santé and Desjardins-Innovatech - $5 million for young Québec health technology enterprises
November 9 2015 - Néomed « The new center is dedicated to biological products and vaccines. »
November 2 2015 - Official Inauguration of the NEOMED Institute – Laval
September 18 2015 - Biotech Finances
August 14 2015 - Two Altasciences Executives Named PharmaVOICE 100 Most Inspiring People in the Life-Sciences Industry
July 17 2015 - Valeant Pharmaceuticals Agrees To Acquire Amoun Pharmaceutical
July 8 2015 - The Biotech City at BIO2015
June 16 2015 - PROMETIC PROVIDES UPDATE REGARDING GENERIUM’S LARGE-SCALE PLASMA PURIFICATION FACILITY
April 17 2015 - Valeant Pharma Acquires Canadian Rights to Altace
April 17 2015 - QUEBEC BIOTECHS FOCUS ON INNOVATION (en français)
March 17 2015 - CiToxLAB Implements Provantis 9 and submit-SEND Solutions
March 17 2015 - Bellus new blog
February 23 2015 - Canada's Valeant to buy Salix
February 20 2015 - Algorithme Pharma CRO Leadership Award recipient
February 17 2015 - US FDA GRANTS ORPHAN DRUG DESIGNATION TO PROMETIC’S PBI-4050 DRUG FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
February 11 2015 - Strategic Alliance in Oncology between Woodland Biosciences and CNBE de l’INRS
February 5 2015 - NEOMED creates a new Biologics and Vaccine Centre of Excellence
December 9 2014 - A visit with Youssef Bennani of Vertex Pharmaceuticals in The Biotech City in Laval
November 10 2014 - KLOX Technologies announces European CE mark approval for acute and chronic wounds treatment - KLOX plans to launch its product LumiHeal™ in 2015
September 24 2014 - Bavarian delegation in Laval
September 9 2014 - The North American Life Science Landscape – Unlocking the Value
August 25 2014 - Valeant Canada acquires Valeo Pharma's portfolio
August 4 2014 - The City of Biotech participated in UBISTART TOUR at the New York Academy of Sciences
July 17 2014 - LEO Pharma & KLOX Technologies strike global dermatology deal
July 17 2014 - Labo BNK introduces the first Chlamydia and Gonorrhea test using the ultra-fast and reliable GeneXpert® molecular diagnostics platform by a private laboratory in Quebec
June 20 2014 - Prometic successfully completes its PBI-4050 Phase I clinical trial
June 13 2014 - CQDM and Sanofi Canada partner to accelerate drug discovery
June 4 2014 - Labo BNK introduces the first Chlamydia and Gonorrhea test using the ultra-fast and reliable GeneXpert® molecular diagnostics platform by a private laboratory in Quebec
June 2 2014 - KneeKG™ : the Quebec knee assessment innovation now in China
May 16 2014 - Sanofi Canada Inspires Next Generation of Canadian Scientists at "Destination Innovation" Event
May 5 2014 - Auven Therapeutics and BELLUS Health Announce Licence Agreement with Mount Sinai for KIACTA(TM) in Sarcoidosis
April 22 2014 - GSK announces approval in Canada for Incruse TM Ellipta TM (umeclidinium) as a treatment for COPD
April 16 2014 - Ergoresearch ingeniosity driving orthopedics
April 10 2014 - PROMETIC’S PBI-4050 DELIVERS NEW POSITIVE PRECLINICAL RESULTS IN LIVER FIBROSIS AND LIVER CANCER
April 2 2014 - Ergoresearch announces the nomination of a C.F.O.
April 2 2014 - ProMetic Reports Successful Pre-IND Meeting with the FDA
March 26 2014 - The Biotech City Announces the Creation of the Contra
March 20 2014 - Industry Recognizes Algorithme Pharma as Preeminent CRO that Surpasses Sponsor Expectations and Provides Greater Value
March 19 2014 - Neptune Appoints John Moretz as Special Advisor and Nominee to Its Board of Directors
February 18 2014 - Valeant gets to the heart of cardiovascular diseases to improve patient treatment
February 17 2014 - SERVIER CANADA invests $10M in two research projects supported by the Partnership Fund for an Innovative, Healthy Quebec
February 14 2014 - Major investment in Emovi knee osteoarthritis program
February 13 2014 - Biotech City to exploit French connections
February 5 2014 - Sanofi Canada: A Partner in Health - Sanofi Canada recognized as one of Montreal's Top Employers
February 3 2014 - Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million
January 31 2014 - BNK Laboratories settles down in the Biotech City
January 29 2014 - The City releases $1 M for the Biocenter Armand-Frappier
January 14 2014 - Laval Technopole: last edition of the economic newsletter
January 9 2014 - Laval prominent in the 2013-2014 retrospective from Biotech-Finances distributed over 580,000 copies worldwide!
January 7 2014 - ProMetic news
December 11 2013 - Algorithme Pharma Gains Key Patient Access Through Partnership with Hôpital Maisonneuve-Rosemont (HMR)
December 11 2013 - Klox Technologies wants to join stock exchange within a year
December 11 2013 - Servier Canada - More alliances with the researchers from Quebec
November 26 2013 - New General Director at Armand-Frappier-INRS University Foundation (French version)
November 19 2013 - PROMETIC RECEIVES $5.1 MILLION PURCHASE ORDER FROM MULTINATIONAL CLIENT
November 19 2013 - KLOX Technologies announces European CE mark approval for its innovative, non-invasive acne vulgaris product
November 15 2013 - ProMetic's PBI-4050 Shown to Reduce Heart Fibrosis
November 13 2013 - Sanofi Canada Earns 2013 Outstanding Partner Award from London Drugs
November 7 2013 - Olympic | $1M investment in the Doping Control Center
October 29 2013 - Algorithme Pharma Signs Strategic Alliance with University of Montreal Hospital Research Centre (CRCHUM)
October 28 2013 - BELLUS Health and AmorChem Announce a Partnership to Develop Drug Candidates for AL Amyloidosis
October 25 2013 - Laboratoire Dr Renaud is now Valeant Groupe Cosméderme Inc.
October 21 2013 - Strategic alliance between Centre de recherche sur les biotechnologies marines in Rimouski and Centre national de biologie expérimentale-INRS
October 16 2013 - MEDFAR Clinical Solutions EMR technology wins government seal of approval
October 4 2013 - Valeant Pharmaceuticals Announces Approval Of Jublia® For The Treatment Of Onychomycosis In Canada
October 2 2013 - KLOX Technologies Announces Approval in Canada of its Innovative Acne Vulgaris Treatment
September 23 2013 - The CNBE will exhibit at the 10th international ISSX meeting
September 19 2013 - JointRep™, a CE-Mark injectable cartilage void-filler-defect repair, for osteoarthritis or trauma injuries, will launch in Europe at the 51st National Congress SCIM, on October 3rd, 2013 in Rimini, Italy
September 11 2013 - KneeKG : a Quebec « knee-electrocardiogram » for the knee now distributed in Australia and New Zealand
September 10 2013 - LAUNCH OF THE NEW CENTRE NATIONAL DE BIOLOGIE EXPERIMENTAL’S WEBSITE
September 10 2013 - KLOX Technologies to present innovative AC-1 biophotonic platform for acne treatment in New York City
September 9 2013 - Servier Canada: An investment of $16.3 million in the life sciences industry and healthcare technologies in Laval
August 27 2013 - Sunshine Biopharma parent company acquires Garmen Laboratories, a certified GMP manufacturing lab
July 11 2013 - KLOX system poised to become leading acne treatment
June 28 2013 - Logi-D helps U.S. hospitals to increase their productivity
June 20 2013 - BELLUS Health to acquire Thallion Pharmaceuticals
June 6 2013 - Québec’s chief scientist launches a Web space for research in Québec
May 30 2013 - GSK acquires Okairos for EUR 250M
May 30 2013 - Two GSK melanoma drugs get FDA approval
May 28 2013 - QBIC receives financial support from Government of Canada
May 27 2013 - Valeant Pharmaceuticals International, Inc. To Acquire Bausch + Lomb For $8.7 Billion
May 6 2013 - Sanofi Canada inaugurates new corporate head office in Laval
May 1 2013 - Jean-Marc Juteau named director of the Biotech City
May 1 2013 - PROMETIC AND SARTORIUS STEDIM BIOTECH JOIN FORCES TO PROMOTE NOVEL TURNKEY SOLUTION FOR PRODUCING PLASMA-DERIVED THERAPEUTICS
March 7 2013 - CQIB named best incubator in Canada by Backbone magazine
February 26 2013 - KLOX’s Innovative AC-1 Biophotonic System proven efficacious and safe in the treatment of moderate to severe Acne
February 26 2013 - Ergoresearch among Canada's top 50 strong performing businesses
February 7 2013 - Klox Technologies: Biopharmacology to Medical Devices
January 22 2013 - Ergoresearch acquires Langelier Orthèses Chaussures
January 16 2013 - A World First for Bio-K+
January 8 2013 - PROMETIC finalizes the strategic equity investment by Shenzhen Hepalink Pharmaceutical
November 30 2012 - KLOX Technologies announced an agreement with Valeant Pharmaceuticals International
November 27 2012 - Ergoresearch announces acquisition of Laboratoire Podotech Inc.
November 12 2012 - BioQuébec and BioTalent Canada Forge Partnership
October 29 2012 - Warnex sells Bioanalytical Business to Biotrial
October 16 2012 - Prometic enters into agreements with Shenzhen Hepalink Pharmaceutical
June 22 2012 - Fondation Armand-Frappier Prizes
June 19 2012 - Appointment of Paul Lirette as President of GlaxoSmithKline Inc.
May 18 2012 - The Crohn’s and Colitis Foundation of Canada and Vertex Announce Collaboration to Fund Research in Inflammatory Bowel Disease
May 2 2012 - Recent advance in knee osteoarthritis
April 24 2012 - Appointment of Ms. Caroline Barbir to the position of General Manager of the Laval CSSS
April 11 2012 - Piramal announces CEE approval of its first innovative product for regenerative medicine, BST-CarGel®
April 10 2012 - Jon Fairest named President and CEO of Sanofi Canada
April 5 2012 - The Biotech City is proud to announce the installation of Valeant Pharmaceuticals International's worldwide Head Office
January 23 2012 - BIOMOMENTUM OBTAINS CE MARKING FOR THE ARTHRO-BST™
December 20 2011 - Valeant Pharmaceuticals Completes Acquisition of Dermik
December 19 2011 - Vertex Announces CEO Succession Plan for 2012
December 12 2011 - Warnex Sells Its Medical and Forensic Testing Operations to Gamma-Dynacare
December 9 2011 - Roche acquires Verum Diagnostica GmbH
December 7 2011 - An investment of $1.5 M within the Québec-Ontario Life Science corridor
December 2 2011 - CQDM presents EXPLORE Competition Program
November 11 2011 - GSK Canada Life Sciences Innovation Fund
November 10 2011 - Harper Government funds Quebec Biotechnology Innovation Centre
August 9 2011 - Grant Program of the Innovation Fund Pfizer-FRSQ
July 21 2011 - Second edition of the Pfizer-FRQS-MSSS competition
July 18 2011 - Warnex announces the reorganization of its Analytical Services Subsidiary
July 11 2011 - Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.
July 8 2011 - Pharmabio Development Annual General Meeting
July 7 2011 - Rémi Quirion is apppointed Chief Scientist of Quebec and will head the Research Fund of Quebec
July 6 2011 - Nano Québec announces new funding program
July 6 2011 - Québec-Europe Call for Proposals on Neurodegenerative Disease Biomarkers (JPND)
June 29 2011 - BiopolisQuébec and Life Sciences Ontario sign a memorandum of understanding
June 29 2011 - Buyandsell.gc.ca, a new website to do business with the federal government
June 22 2011 - Labopharm announces intention to delist from NASDAQ
June 15 2011 - International ConneXions at Bio2011
June 8 2011 - 2011 BIO International Convention, Washington DC
June 2 2011 - A new pharmaceutical member at CQDM
May 27 2011 - Valeant Pharmaceuticals Agrees to Acquire Sanitas Group for approximately EUR314 Million in Cash
May 25 2011 - Vertex's drug approval for Hepatitis C
May 20 2011 - Monitor Clipper Partners Acquires Pharmetics
April 29 2011 - Sanofi-aventis’ Innovative «Met Buster» earns Quebec safety prize
April 20 2011 - Future scientific lawyers from Sherbrooke University are now available to support your company
April 19 2011 - Large Leningrad delegation interested in Laval’s BIOPOLE and its dedicated site: The Biotech City
April 15 2011 - JRH-Orthofab Rehabili-Thon 3rd Annual
April 13 2011 - LAB Research agrees to sell assets; business activities to continue
April 13 2011 - NanoQuébec launches an all-new funding program
April 6 2011 - ProMetic enters into global agreement with Celgene Corporation
April 6 2011 - Bellus Health and the Agahan group enter into broad license for Vivimind TM in the middle east.
March 28 2011 - Labopharm announces workforce reduction and appointment of new CFO
March 3 2011 - CQDM welcomes two new members and launch the Explore program
March 3 2011 - CQDM is please to launch its new competition « EXPLORE »
March 1 2011 - Internship program administered by MITACS
February 16 2011 - SGF Reinvests US$14.7M in Axcan Pharma
February 3 2011 - Merck Canada invests $5 Million in Quebec Consortium for Drug Discovery
February 3 2011 - Bellus Health announces phase 1 results of prodrug NRM8499
February 2 2011 - Internships in Biomedical Engineering, students from the Ecole Polytechnique de Montreal
January 28 2011 - Additional financial support for LAB Research
January 25 2011 - BIOCOM's 1st Annual Global Life Science Partnering Conference
January 21 2011 - Labopharm receives Health Canada approval for OLEPTRO™
January 20 2011 - Major investment in Oncology Reaseach Program
January 19 2011 - Come meet the e-POLE and BIOPOLE for an Exclusive Wine and Cheese Event
January 18 2011 - «BIOPARTENARIATS Europe» (Milan & London) March 14-18, 2011
May 19 2010 - The Biotech City at the BIO International Convention in Chicago
April 28 2010 - The Laval Biotech City developing partenerships at Bio International Convention in Chicago
 
 
Devrun ©2017 The Biotech City